HealthLynked (OTCQB: HLYK), a Naples, Florida-based leader in personalized healthcare and patient-centric services, leverages technology to provide innovative solutions to healthcare problems, ensuring more efficient, accessible, and personalized healthcare for all. At the heart of the company’s mission is an unwavering determination to transform healthcare on a global scale with the aim of improving the medical practice efficiency and, as a result, increasing the reach of high-quality healthcare services and ensuring more accurate medical diagnosis (https://ibn.fm/uD0Ww).
“The current healthcare system is fragmented and inefficient, often leaving patients frustrated and underserved. At HealthLynked, we are pioneering a new era of healthcare that prioritizes seamless connectivity, personalized care, and data-driven insights,” explained Dr. Michael Dent, CEO of HealthLynked, in a June 5 news release.
The company’s founder and a visionary in the healthcare industry, Dr. Dent has led HealthLynked in developing an expansive array of innovative products and services. Among them is the company’s comprehensive healthcare platform, the HealthLynked Network System, that securely, efficiently, and cost-effectively connects patients, healthcare providers, and medical facilities.
The platform supports a range of services, including online medical records storage, online appointment scheduling for doctors nationwide, telemedicine, and patient engagement tools. According to the company, the healthcare platform aims to improve patient outcomes and increase efficiency throughout the healthcare system (https://ibn.fm/dytnu). In addition to its platform’s offerings, HealthLynked offers additional services: an e-commerce platform for over 15,000 name-brand medical supplies, concierge patient support, nurse chat, a reward points program, and co-management of family members’ healthcare.
To ensure that more patients and healthcare providers can benefit from these innovative solutions and services, HealthLynked recently received $1 million in financing from its CEO Dr. Dent (https://ibn.fm/bME0G). According to the June 5 announcement, the financing is expected to provide HealthLynked with an additional capital runway for accelerating its growth and expanding its offerings further.
“Providing funding to HealthLynked is a testament to my belief in the transformative power of our services and our mission to create a more efficient healthcare system for the benefit of everyone,” commented Dr. Dent. “This financing is not just about financial growth; it’s about leading the way to a more efficient healthcare system of the future, protecting our shareholders’ interests, and assisting our continued success in revolutionizing the healthcare industry.”
Dave Rosal, CFO of HealthLynked, believes this funding will allow the company to “enhance our service offerings and reach more patients and healthcare providers, ultimately driving shareholder value and solidifying our market position in the market.” He also notes that the financing demonstrates Dr. Dent’s commitment to the company, which, in turn, spotlights the strength of its business model and confidence in its strategic direction.
HealthLynked believes this new financing sets it on a path for even greater success and impact in the healthcare sector. It also boosts the company’s efforts to continue to innovate and expand its reach, providing vital healthcare solutions that cater to the needs of patients and healthcare providers.
For more information, visit the company’s website at www.HealthLynked.com.
NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYK
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
San Francisco, CA
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective…
A team of researchers has leveraged a technique called temporal learning to train an AI…
Sheridan was recently named as a finalist for the 2025 EY Entrepreneur of the Year…
“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected…
Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive…
A new study focusing on twins has found that individuals with a larger presence of…